Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment

Journal of Pharmacology and Experimental Therapeutics

Volumn 305, Issue 1, 2003, Pages 70-77

  Fujino, Masayuki ^a   Funeshima, Naoko ^a   Kitazawa, Yusuke ^a   Kimura, Hiromitsu ^a   Amemiya, Hiroshi ^a   Suzuki, Seiichi ^a   Li, Xiao Kang ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FINGOLIMOD; FREUND ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 6; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; BRAIN PROTECTION; CONTROLLED STUDY; DEMYELINATING DISEASE; DRUG EFFICACY; DRUG MECHANISM; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; TH1 CELL;

ANIMALS; APOPTOSIS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOSUPPRESSIVE AGENTS; MALE; PROPYLENE GLYCOLS; RATS; RATS, INBRED LEW; SPHINGOSINE; T-LYMPHOCYTES;

EID: 0037379202     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.045658     Document Type: Article

References (40)

1. Ando DG, Clayton J, Kono D, Urban JL, and Sercarz EE (1989) Encephalitogenic T cells in the B10. PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol 124:132-143.
2. Bolton C (1992) The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE). PG. Agents Actions 35:79-84.
3. Bolton C, Allsopp G, and Cuzner ML (1982a) The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat. Clin Exp Immunol 47:127-132.
4. Bolton C, Borel JF, Cuzner ML, Davison AN, and Turner AM (1982b) Immunosuppression by cyclosporin A of experimental allergic encephalomyelitis. J Neurol Sci 56:147-153.
5. Bonetti B, Pohl J, Gao YL, and Raine CS (1997) Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J Immunol 159:5733-5741.
6. Borel JF (1990) Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo. Pharmacol Rev 41:259-371.
7. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, et al. (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277:21453-21457.
8. Brinkmann V, Pinschewer DD, Feng L, and Chen S (2001) FTY720: altered lymphocyte traffic results in allograft protection. Transplantation 72:764-769.
9. Chiba K, Yanagawa Y, Masubuchi Y, Kataoka H, Kawaguchi T, Ohtsuki M, and Hoshino Y (1998) FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 160:5037-5044.
10. Deguchi K, Takeuchi H, Miki H, Yamada A, Touge T, Terada S, and Nishioka M (1991) Effects of FK 506 on acute experimental allergic encephalomyelitis. Transplant Proc 23:3360-3362.
11. Enosawa S, Suzuki S, Kakefuda T, Li XK, and Amemiya H (1996) Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720. Immunopharmacology 34:171-179.
12. Fujita T, Inoue K, Yamamoto S, Ikumoto T, Sasaki S, Toyama R, Chiba K, Hoshino Y, and Okumoto T (1994a) Fungal metabolites. Part II. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J Antibiot (Tokyo) 47:208-215.
13. Fujita T, Inoue K, Yamamoto S, Ikumoto T, Sasaki S, Toyama R, Yoneta M, Chiba K, Hoshino Y, and Okumoto T (1994b) Fungal metabolites. Part 12. Potent immunosuppressant, 14-deoxomyriocin, (2S,3R,4R)-(E)-2-amino-3, 4-dihydroxy-2hydroxymethyleicos-6-anoic acid and structure-activity relationships of myriocin derivatives. J Antibiot (Tokyo) 47:216-224.
14. Hickey WF, Hsu BL, and Kimura H (1991) T-Lymphocyte entry into the central nervous system. J Neurosci Res 28:254-260.
15. Hoshino Y, Suzuki C, Ohtsuki M, Masubuchi Y, Amano Y, and Chiba K (1996) FTY720, a novel immunosuppressant possessing unique mechanisms. II. Longterm graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Transplant Proc 28:1060-1061.
16. Hozumi Y, Kobayashi E, Miyata M, and Fujimura A (1999) Immunotherapy for experimental rat autoimmune thyroiditis using a novel immunosuppressant, FTY720. Life Sci 65:1739-1745.
17. Inamura N, Hashimoto M, Nakahara K, Nakajima Y, Nishio M, Aoki H, Yamaguchi I, and Kohsaka M (1988) Immunosuppressive effect of FK506 on experimental allergic encephalomyelitis in rats. Int J Immunopharmacol 10:991-995.
18. Kitabayashi H, Isobe M, Watanabe N, Suzuki J, Yazaki Y, and Sekiguchi M (2000) FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes. J Cardiovasc Pharmacol 35:410-416.
19. Kurose S, Ikeda E, Tokiwa M, Hikita N, and Mochizuki M (2000) Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats. Res 70:7-15.
20. Lee SJ and Benveniste EN (1999) Adhesion molecule expression and regulation on cells of the central nervous system. J Neuroimmunol 98:77-88.
21. Li XK, Tamura A, Fujino M, Guo L, Kakefuda T, Funeshima N, Enosawa S, Amari M, Naoe S, Amemiya H, and Suzuki S (2001) Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720. Clin Exp Immunol 123:331-339.
22. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, and Schreiber SL (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-815.
23. MacPhee IA and Mason DW (1988) Evidence for an immunosuppressive autoantibody in experimental allergic encephalomyelitis. Ann N Y Acad Sci 540:718-719.
24. Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, et al. (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science (Wash DC) 296:346-349.
25. McWhinnie DL and Morris PJ (1991) Combination drug therapies for immunosuppression in transplantation. Ann Acad Med Singapore 20:498-502.
26. Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, and Minota S (2002) Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. J Rheumatol 29:707-716.
27. Panitch HS and McFarlin DE (1977) Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A. J Immunol 119:1134-1137.
28. Paterson PY (1960) Transfer for allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med 111:119-135.
29. Pender MP, Nguyen KB, McCombe PA, and Kerr JF (1991) Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 104:81-87.
30. Pinschewer DD, Ochsenbein AF, Odermatt B, Brinkmann V, Hengartner H, and Zinkernagel RM (2000) FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion and memory. J Immunol 164:5761-5770.
31. Platz KP, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, and Neuhaus P (1994) Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK506-treated patients. Transpl Int 7:S52-S57.
32. Richert JR, Driscoll BF, Kies MW, and Alvord EC Jr (1979) Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen. J Immunol 122:494-496.
33. Samoilova EB, Horton JL, Hilliard B, Liu TS, and Chen Y (1998) IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol 161:6480-6486.
34. Schmitz GG, Walter T, Seibl R, and Kessler C (1991) Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Anal Biochem 192:222-231.
35. Sun JB, Xiao BG, Lindblad M, Li BL, Link H, Czerkinsky C, and Holmgren J (2000) Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-β-secreting cells and suppressing chemokine expression. Int Immunol 12:1449-1457.
36. Suzuki S, Enosawa S, Kakefuda T, Amemiya H, Hoshino Y, and Chiba K (1996a) Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720. Transplant Proc 28:1375-1376.
37. Suzuki S, Enosawa S, Kakefuda T, Shinomiya T, Amari M, Naoe S, Hoshino Y, and Chiba K (1996b) A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 61:200-205.
38. Yan H, Suzuki K, Li XK, Amemiya H, Suzuki S, and Hiromitsu K (1998) Immunosuppressive effect of FTY 720 on autoimmune diabetes models. Transplant Proc 30:3436-3437.
39. Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, and Chiba K (1998) FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol 160:5493-5499.
40. Zamvil SS and Steinman L (1990) The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 8:579-621.